To comply with the new DSCSA, manufacturers are to investing in the systems, equipment and processes to ensure that their drugs are serialized at each level of packaging. It will be a significant investment regardless of size.
In 2004 and 2005, Florida and California legislators enacted laws to require drug companies to secure their supply chains. The two states called for the serialization of any drugs entering the states to be captured and tracked. The law also called for a system of reporting on drugs as they moved from manufacturing all the way through to the pharmacy or physician. These two states, with their population size, held force in these efforts.Download